Immunocore Holdings Plc Shs Sponsored American Depositary Shares Repr 1 Sh IMCR 深 沪
交易中 01-28 10:47:40 美东时间
33.70
-1.350
-3.85%
华盛通- 最 高35.20
- 今 开35.11
- 成交量 15.44万股
- 最 低 33.31
- 昨 收 35.05
- 总市值 16.98亿
- 52周最高 40.7147
- 市盈率 静 --
- 换手率 0.00%
- 52周最低 23.15
- 委 比 -33.77%
- 总股本 5038.71万
- 历史最高 76.98
- 量 比 1.45
- 振 幅 5.39%
- 历史最低 18.43
- 每 手 1
- 风险率 3.03%
个股概要
财务分析
公司资料
相关新闻
分红派息
- 分时图
- 日k
- 周k
- 月k
相关新闻
更多Immunocore Sets 2026 Strategic Priorities for Melanoma Growth
Immunocore Holdings ( ($IMCR) ) has issued an announcement. On January 9, 2026,...
01-09 20:28
Immunocore announces 2026 strategic priorities at 44th Annual J.P. Morgan Healthcare Conference
Immunocore announced its 2026 strategic priorities at the 44th J.P. Morgan Healthcare Conference, including expanding KIMMTRAK's reach for metastatic uveal melanoma patients, completing enrollment in the TEBE-AM Phase 3 trial by mid-2026, presenting PRAME franchise data in ovarian and lung cancer, and advancing autoimmune and infectious disease candidates. The company also highlighted its financial position with $864 million in cash as of Decembe...
01-09 12:00
Immunocore Holdings Board Member Ranjeev Krishana Resigns
The latest announcement is out from Immunocore Holdings ( ($IMCR) ). On Novembe...
2025-11-28 20:28
美股大行评级 | 花旗上调英伟达目标价从210美元升至220美元；DraftKings、DoubleVerify遭多家大行下调目标价
今日重点评级关注：Guggenheim：维持InflaRx"买入"评级，目标价从10美元升至22美元；巴克莱：维持Tandem糖尿病护理"超配"评级，目标价从51美元升至55美元
2025-11-11 10:49
Morgan Stanley Maintains Equal-Weight on Immunocore Holdings, Raises Price Target to $36
Morgan Stanley analyst Andrew Galler maintains Immunocore Holdings (NASDAQ:IMCR) with a Equal-Weight and raises the price target from $34 to $36.
2025-11-11 01:54
Immunocore to present at upcoming investor conferences
Immunocore Holdings plc announced its participation in two healthcare conferences in November 2025. The Guggenheim 2nd Annual Healthcare Innovation Conference will feature a fireside chat on November 11, 2025, at 3:00 p.m. EST. Additionally, Immunocore will participate in the Jefferies London Healthcare Conference with a fireside chat on November 19, 2025, at 3:30 p.m. GMT. Presentations will be available live via webcast and on Immunocore’s webs...
2025-11-10 12:00
Immunocore Hldgs Q3 Sales $103.693M Beat $100.186M Estimate
Immunocore Hldgs (NASDAQ:IMCR) reported quarterly sales of $103.693 million which beat the analyst consensus estimate of $100.186 million by 3.50 percent. This is a 29.22 percent increase over sales of $80.248 million
2025-11-06 20:28
美股大行评级 | 苹果、亚马逊、Cloudflare、西部数据、Twilio等获十多家机构集体上调目标价；杰富瑞首予Cloudflare"持有"评级，目标价250美元
今日重点评级关注：康托·菲茨杰拉德：维持Cabaletta Bio"超配"评级，目标价从15美元升至30美元；HC Wainwright & Co.：维持Invivyd"买入"评级，目标价从5美元升至10美元
2025-11-03 20:20
Wells Fargo Initiates Coverage On Immunocore Holdings with Overweight Rating, Announces Price Target of $60
Wells Fargo analyst Eva Fortea Verdejo initiates coverage on Immunocore Holdings (NASDAQ:IMCR) with a Overweight rating and announces Price Target of $60.
2025-11-01 05:02
华尔街顶级分析师最新评级：苹果获上调，康卡斯特遭下调
华尔街最受关注、且可能影响市场走势的研究评级报告现已汇总。以下是由 The Fly 整理的今日投资者需重点关注的分析师评级变动信息。 五大评级上调案例： ...
2025-10-31 22:42
